Unicycive investors get lawsuit deadline reminder
Rosen Law Firm said investors who bought Unicycive Therapeutics shares in a specified class period have until Nov. 2, 2026, to seek lead-plaintiff status in an already filed securities lawsuit.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.